Once A Year Osteoporosis Treatment

Featured Health Expert

Zoledronic Acid Approved in Canada for Postmenopausal Osteoporosis

Zoledronic acid, a once-yearly infusion, has been approved by Health Canada for treatment of postmenopausal osteoporosis. Known as Reclast in the U.S., the bisphosphonate medication received FDA approval for that purpose just a few months ago. It will be sold as Aclasta in Canada and will help provide osteoporosis patients in the country one more option for strengthening their bones.
Read more

More information on "Once A Year Osteoporosis Treatment"

From Our Experts

See more SharePosts »

From Our Sources

More on Osteoporosis »